LOR is the first drug candidate with disease-modifying potential for osteoarthritis submitted for approval, demonstrating ...

Wiley, a global leader in authoritative content and research intelligence, today announces the launch of the Nanalysis ...

NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, today announces that Thomas Holm Pedersen, Chief ...

According to MarketsandMarkets, the report "Pharma & Cosmetic Anti-Counterfeit Packaging Market by Technology (Mass Encoding, RFID, Tamper Evidence, Hologram, Others) and Region (North America, Europe ...

AbbVie announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and pediatric ...